Back to search

Article

Genomic profiling of cancerous patients identifies FPR2 as an alternative immunotherapeutic target in glioblastoma multiforme

2020-12-27

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Glioblastoma multiforme (GBM) is a type of high-grade brain tumor known for its proliferative, invasive property, and low survival rate. Recently, with the advancement in therapeutics for tumors such as targeted therapy, individual cancer-specific biomarkers could be recognized as targets for curative purposes. This study identified six differentially expressed genes that ha...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d6e48026-2f67-572f-b859-e54bc298d365
DOI
10.1101/2020.12.26.424414
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Genomic profiling of cancerous patients identifies FPR2 as an alternative immunotherapeutic target in glioblastoma multiformeDOI 10.1101/2020.12.26.424414
Select a neighboring publication to make it the new centre.